Physician profile
Glenn R Davis
NPI 1568450757
$2,695,724.03
in general payments reported to CMS, 2019-2025
4 companies · $681K in 2025
The $681K reported for 2025 was more than what 99% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $129K · 2020: $328K · 2021: $343K · 2022: $511K · 2023: $260K · 2024: $444K · 2025: $681K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $1.4M.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $1,384,852.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Affordable Pharmaceuticals, LLC | $1,671,547.35 | 2019-2025 | Peg-3350 and Electrolytes, Peg-3350, Sodium Chloride, Sodium Bicarbonate and Potassium Chloride |
| Braintree Laboratories, INC. | $1,024,087.95 | 2020-2025 | Golytely |
| Abbvie INC. | $69.41 | 2021-2022 | |
| Boston Scientific Corporation | $19.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Glenn Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.